1
|
Derivation of Oligodendrocyte Precursors from Adult Bone Marrow Stromal Cells for Remyelination Therapy. Cells 2021; 10:cells10082166. [PMID: 34440935 PMCID: PMC8391516 DOI: 10.3390/cells10082166] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Revised: 08/12/2021] [Accepted: 08/13/2021] [Indexed: 01/04/2023] Open
Abstract
Transplantation of oligodendrocyte precursors (OPs) is potentially therapeutic for myelin disorders but a safe and accessible cell source remains to be identified. Here we report a two-step protocol for derivation of highly enriched populations of OPs from bone marrow stromal cells of young adult rats (aMSCs). Neural progenitors among the aMSCs were expanded in non-adherent sphere-forming cultures and subsequently directed along the OP lineage with the use of glial-inducing growth factors. Immunocytochemical and flow cytometric analyses of these cells confirmed OP-like expression of Olig2, PDGFRα, NG2, and Sox10. OPs so derived formed compact myelin both in vitro, as in co-culture with purified neurons, and in vivo, following transplantation into the corpus callosum of neonatal shiverer mice. Not only did the density of myelinated axons in the corpus callosum of recipient shiverer mice reach levels comparable to those in age-matched wild-type mice, but the mean lifespan of recipient shiverer mice also far exceeded those of non-recipient shiverer mice. Our results thus promise progress in harnessing the OP-generating potential of aMSCs towards cell therapy for myelin disorders.
Collapse
|
2
|
Zhao Y, Tian C, Wu P, Chen F, Xiao A, Ye Q, Shi X, Wang Z, Han X, Chen Y. Hydroxypropyl chitosan/soy isolate protein conduits promote peripheral nerve regeneration. Tissue Eng Part A 2021; 28:225-238. [PMID: 34375147 DOI: 10.1089/ten.tea.2021.0068] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
Designing scaffolds, with optimized micro-structure and function for promoting the release of neuro-related factors, is significant in peripheral nerve regeneration. Herein, a series of hydroxypropyl chitosan/soy protein isolate composite sponges (HCSS) were fabricated by a freeze-drying technique. The physicochemical properties of the resultant HCSS were examined by a Fourier infrared spectrometer, X-ray diffractometer, scanning electron microscope, water absorption assay, water retention assay, and compressive strength assay. The results indicated that HCSS exhibited an interconnected porous micro-structure and a high water retention ratio with the increase in SPI content. The biological characterization found that the HCSS-50 containing 50% SPI content profoundly promoted the proliferation of RSC96 cells and the secretion of neuro-related factors without excessive ROS production. In addition, HCSS-50 could significantly promote the expression of neuro-related factors; for example, the expression of TGF-β was 3 times higher than that of the control group. Finally, an optimized HCSS-based conduit was fabricated from HCSS-50 to repair sciatic nerve injury in rats with the combination of BMSCs or BMSC-derived Schwann cells. The results suggested that the constructed HCSS-based conduit accompanying BMSC-derived Schwann cells could effectively promote axonal regeneration and upregulate expression of neuro-related factors such as Krox20, Zeb2, and GAP43. Collectively, a newly engineered nerve conduit system was developed by incorporating HCSS-50 and BMSC-derived Schwann cells, which could be an alternative candidate for peripheral nerve regeneration.
Collapse
Affiliation(s)
- Yanan Zhao
- Zhengzhou University First Affiliated Hospital, 191599, Zhengzhou, Henan, China.,Wuhan University School of Basic Medical Sciences, 36841, Wuhan, China;
| | - Chuan Tian
- Zhengzhou University First Affiliated Hospital, 191599, Zhengzhou, Henan, China;
| | - Ping Wu
- Wuhan University School of Basic Medical Sciences, 36841, Wuhan, China;
| | - Feixiang Chen
- Wuhan University School of Basic Medical Sciences, 36841, Wuhan, China;
| | - Ao Xiao
- Wuhan University School of Basic Medical Sciences, 36841, Wuhan, China;
| | - Qifa Ye
- Wuhan University Zhongnan Hospital, 89674, Wuhan, Hubei , China;
| | - Xiaowen Shi
- Wuhan University, 12390, School of Resource and Environmental Science, Wuhan, Hubei , China;
| | - Zijian Wang
- Wuhan University School of Basic Medical Sciences, 36841, Wuhan, China;
| | - Xinwei Han
- Zhengzhou University First Affiliated Hospital, 191599, Zhengzhou, Henan, China;
| | - Yun Chen
- Wuhan University School of Basic Medical Sciences, 36841, 115 Donghu Road, Wuchang District, Wuhan, China, Wuhan, China, 430071;
| |
Collapse
|